瑞德昔韦-话题@MedSci - 梅斯（MedSci）

#瑞德昔韦#

5篇内容 | 995人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1573595, encodeId=19c915e3595b3, content=<a href='/topic/show?id=f6b768e230b' target=_blank style='color:#2F92EE;'>#瑞德昔韦#</a>, objectTitle=瑞德昔韦联合血浆来源中和抗体：开展III期临床评价抗新冠病毒COVID-19的有效性, objectType=article, longId=201999, objectId=9dcd20199981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dcd20199981, replyNumber=0, likeNumber=87, createdTime=2020-10-13, rootId=0, userName=jjjiang0204, userId=a58d15911978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dcd20199981, moduleTitle=瑞德昔韦联合血浆来源中和抗体：开展III期临床评价抗新冠病毒COVID-19的有效性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9dcd20199981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573594, encodeId=7ffd15e359448, content=<a href='/topic/show?id=f6b768e230b' target=_blank style='color:#2F92EE;'>#瑞德昔韦#</a>, objectTitle=辉瑞公司将生产瑞德昔韦，增加产能, objectType=article, longId=199064, objectId=9657199064f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9657199064f3, replyNumber=0, likeNumber=61, createdTime=2020-08-11, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9657199064f3, moduleTitle=辉瑞公司将生产瑞德昔韦，增加产能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9657199064f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573593, encodeId=301115e35933c, content=<a href='/topic/show?id=f6b768e230b' target=_blank style='color:#2F92EE;'>#瑞德昔韦#</a>, objectTitle=吉利德开始测试吸入型瑞德昔韦, objectType=article, longId=196357, objectId=f74719635ead, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f74719635ead, replyNumber=0, likeNumber=71, createdTime=2020-06-25, rootId=0, userName=jjjiang0204, userId=a58d15911978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f74719635ead, moduleTitle=吉利德开始测试吸入型瑞德昔韦, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f74719635ead)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573592, encodeId=404615e3592cc, content=<a href='/topic/show?id=f6b768e230b' target=_blank style='color:#2F92EE;'>#瑞德昔韦#</a>, objectTitle=重症新冠肺炎患者应用瑞德昔韦有获益！新英格兰医学杂志研究：需谨慎对待，不能过早乐观, objectType=article, longId=192241, objectId=8e8a19224155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e8a19224155, replyNumber=0, likeNumber=49, createdTime=2020-04-16, rootId=0, userName=jjjiang0204, userId=a58d15911978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e8a19224155, moduleTitle=重症新冠肺炎患者应用瑞德昔韦有获益！新英格兰医学杂志研究：需谨慎对待，不能过早乐观, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8e8a19224155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573591, encodeId=622b15e3591e8, content=<a href='/topic/show?id=f6b768e230b' target=_blank style='color:#2F92EE;'>#瑞德昔韦#</a>, objectTitle=NEJM：重症新冠肺炎患者应用瑞德昔韦有获益！, objectType=article, longId=192109, objectId=1449192109a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1449192109a5, replyNumber=0, likeNumber=58, createdTime=2020-04-14, rootId=0, userName=jjjiang0204, userId=a58d15911978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1449192109a5, moduleTitle=NEJM：重症新冠肺炎患者应用瑞德昔韦有获益！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1449192109a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

瑞德昔韦

2020-05-29

jjjiang0204 (审核中...)

前往app查看评论内容

#瑞德昔韦#

瑞德昔韦联合血浆来源中和抗体：开展III期临床评价抗新冠病毒COVID-19的有效性

2020-10-13

智智灵药 (审核中...)

前往app查看评论内容

#瑞德昔韦#

辉瑞公司将生产瑞德昔韦，增加产能

2020-08-11

jjjiang0204 (审核中...)

前往app查看评论内容

#瑞德昔韦#

吉利德开始测试吸入型瑞德昔韦

2020-06-25

jjjiang0204 (审核中...)

前往app查看评论内容

#瑞德昔韦#

重症新冠肺炎患者应用瑞德昔韦有获益！新英格兰医学杂志研究：需谨慎对待，不能过早乐观

2020-04-16

jjjiang0204 (审核中...)

前往app查看评论内容

#瑞德昔韦#

NEJM：重症新冠肺炎患者应用瑞德昔韦有获益！

2020-04-14

科室
- - 订阅+
  - 更多科室
工具
服务